Expression of cancer stem cell biomarkers as a tool for a correct therapeutic approach to hepatocellular carcinoma

Maurizio Romano, Francesco De Francesco, Giuseppe Pirozzi, Enrico Gringeri, Riccardo Boetto, Marina Di Domenico, Barbara Zavan, Giuseppe A. Ferraro, Umberto Cillo

Research output: Contribution to journalArticlepeer-review

Abstract

Liver cancer is the fifth most commonly diagnosed malignancy and the second most frequent cause of cancer death in men worldwide. Amongst liver cancers, hepatocellular carcinoma (HCC) represents the major histological subtype and it is one of the most common malignant human tumors worldwide. Research into the molecular biology of hepatocarcinogenesis has identified several biomarkers, which could provide additional informations in order to better understand the biology of HCC. A large number of biomarkers have been shown to have potential predictive significance and a wide variety of molecular markers have been proven to be excellent diagnostic tools for HCC but it is difficult to characterize HCC with a single biomarker. Thus, signatures of a combination of biomarkers may be more valuable for the diagnosis, staging and prognosis of HCC. Specifically, a correlation of HCC-CSCs phenotype to specific hepatic cancer subtypes and to specific clinical and pathological features has not yet been reported in human liver tumors. In this view we will first discuss the possible sources of liver stem cells and their relation with liver cancer development and we will secondly focus on the prognostic significance of clinical and pathological features of HCC.

Original languageEnglish
Pages (from-to)443-456
Number of pages14
JournalOncoscience
Volume2
Issue number5
DOIs
Publication statusPublished - 2015

Keywords

  • Biomarkers
  • Clinic-pathological
  • Early diagnosis
  • Hepatocellular carcinoma
  • Prognosis

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Fingerprint Dive into the research topics of 'Expression of cancer stem cell biomarkers as a tool for a correct therapeutic approach to hepatocellular carcinoma'. Together they form a unique fingerprint.

Cite this